HEPATITIS B, CHRONIC
Clinical trials for HEPATITIS B, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Step therapy shows promise against chronic hepatitis b
Disease control CompletedThis study tested a new two-step treatment for adults with chronic hepatitis B who are already on standard antiviral medication. The treatment involves first giving an experimental drug (ASO) for 12 or 24 weeks, followed by a targeted immunotherapy. The goal was to see if this ap…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New shot aims to tame hepatitis b in early trial
Disease control CompletedThis study tests a new drug, AHB-137, given as a shot under the skin. It first checks safety in healthy volunteers, then tests how well it works in people with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if AHB-137 can lower or clear the he…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for hepatitis b: combination therapies under study
Disease control CompletedThis study tested new combinations of drugs in 281 people with chronic hepatitis B who had stable liver function. Participants took the study drugs for up to 48 weeks and were monitored for safety and whether they lost the hepatitis B surface antigen (a key sign of infection cont…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hepatitis b cocktail shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether combining two experimental drugs (VIR-2218 and VIR-3434) with or without a standard immune booster (PEG-IFNα) can safely clear the hepatitis B virus from the blood. 244 adults with chronic hepatitis B who were already on antiviral therapy took part. The …
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for hepatitis b: drug combo trial shows promise
Disease control CompletedThis study tested new drug combinations for adults with chronic hepatitis B, a long-term liver infection. The goal was to see if these treatments could lower the virus to undetectable levels and reduce a key marker of infection (HBsAg). 33 adults took part, and the study looked a…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC